AU7697500A - Acth treatment of steroid- and statin-treated patients - Google Patents

Acth treatment of steroid- and statin-treated patients

Info

Publication number
AU7697500A
AU7697500A AU76975/00A AU7697500A AU7697500A AU 7697500 A AU7697500 A AU 7697500A AU 76975/00 A AU76975/00 A AU 76975/00A AU 7697500 A AU7697500 A AU 7697500A AU 7697500 A AU7697500 A AU 7697500A
Authority
AU
Australia
Prior art keywords
statin
steroid
treated patients
acth treatment
acth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76975/00A
Inventor
Margret Arnadottir
Anna-Lena Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7697500A publication Critical patent/AU7697500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76975/00A 1999-09-29 2000-09-29 Acth treatment of steroid- and statin-treated patients Abandoned AU7697500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15659099P 1999-09-29 1999-09-29
US60156590 1999-09-29
PCT/SE2000/001880 WO2001022991A1 (en) 1999-09-29 2000-09-29 Acth treatment of steroid- and statin-treated patients

Publications (1)

Publication Number Publication Date
AU7697500A true AU7697500A (en) 2001-04-30

Family

ID=22560203

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76975/00A Abandoned AU7697500A (en) 1999-09-29 2000-09-29 Acth treatment of steroid- and statin-treated patients

Country Status (2)

Country Link
AU (1) AU7697500A (en)
WO (1) WO2001022991A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2187940B1 (en) * 2007-09-11 2013-01-30 Mondobiotech Laboratories AG Use of urocortin optionally together with corticotropin-releasing factor as therapeutic agents

Also Published As

Publication number Publication date
WO2001022991A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU7735200A (en) Treatment of tissue by application of energy and drugs
AU5032500A (en) Treatment of irregular ventricular contractions
AU5215300A (en) Dental treatment area
AU3896900A (en) Treatment of pain
AU7106300A (en) Treatment of skin disorders
NZ513686A (en) Treatment of trauma
AU1878201A (en) Composition for the treatment of damaged tissue
GB9927757D0 (en) Treatment of autoimmune diseases
AU2432001A (en) Treatment of mental conditions including depression
AU3760900A (en) Treatment of menstrual function
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2566201A (en) Compounds and methods for the treatment of pain
AU1405001A (en) Treatment of diseases
AU1618901A (en) Treatment of rosacea
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU7697500A (en) Acth treatment of steroid- and statin-treated patients
AU4605500A (en) Medical membrane for stimulating tissue formation
AU2683500A (en) Compositions for the treatment of pain
AU4598400A (en) Method of treatment
AU2467500A (en) Combination of plasters for galvanic treatment of medical problems
AU7455300A (en) The band combined medical treatment of ion
AU2420201A (en) Compounds and methods for the treatment of pain
AU7975500A (en) Drug for treatment of immunodeficiency states

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase